Journey Medical Corporation has entered into a new At Market Issuance Sales Agreement with B. Riley Securities, Inc. and Lake Street Capital Markets, LLC. This agreement allows the company to offer and sell up to 3,750,000 shares of its common stock at its discretion. The shares will be issued under the company's registration statement that was declared effective earlier this year. This new agreement replaces the previous one with B. Riley, which has now been terminated. The company is not obligated to sell any shares under the agreement, which will remain active until all shares are sold or the agreement is terminated according to its terms.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Journey Medical Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-25-084879), on August 28, 2025, and is solely responsible for the information contained therein.